![Ronald Eastman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald Eastman
Directeur/Membre du Conseil chez
EPIPHANY TECHNOLOGY ACQUISITION CORP.
Profil
Ronald Welcome Eastman is currently the Vice Chairman at BioPlus Acquisition Corp.
He is also a Director at IntegenX, Inc., Medical, Inc., Suneva Medical, Inc., Juvenile Diabetes Research Foundation of Arizona, Inc., and an Independent Director at Epiphany Technology Acquisition Corp.
and Enterprise 4.0 Technology Acquisition Corp.
Additionally, he serves as a Senior Advisor at Essex Woodlands Management, Inc. Mr. Eastman previously held positions as the Chief Executive Officer at Geron Corp.
and Rinat Neuroscience Corp.
He was also a Managing Director & Managing Partner at EW Healthcare Partners Fund.
Furthermore, he has served as an Independent Director at Revance Therapeutics, Inc., EyePoint Pharmaceuticals, Inc., and Corium International, Inc. Mr. Eastman has an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Williams College.
Postes actifs de Ronald Eastman
| Sociétés | Poste | Début |
|---|---|---|
| BIOPLUS ACQUISITION CORP. | Directeur/Membre du Conseil | 01/12/2021 |
| EPIPHANY TECHNOLOGY ACQUISITION CORP. | Directeur/Membre du Conseil | 23/09/2022 |
| ENTERPRISE 4.0 TECHNOLOGY ACQUISITION CORP. | Directeur/Membre du Conseil | 21/04/2023 |
Medical, Inc.
 Medical, Inc. Medical DistributorsDistribution Services Wholesales and repairs medical equipment | Directeur/Membre du Conseil | - |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Private Equity Investor | 01/10/2006 |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Directeur/Membre du Conseil | 01/01/2016 |
Juvenile Diabetes Research Foundation of Arizona, Inc. | Directeur/Membre du Conseil | - |
IntegenX, Inc.
 IntegenX, Inc. BiotechnologyHealth Technology Develops rapid human DNA identification technology, next-gen sequencing library preparation, and DNA/RNA ambient temperature stability and storage products | Directeur/Membre du Conseil | - |
Anciens postes connus de Ronald Eastman
| Sociétés | Poste | Fin |
|---|---|---|
| EYEPOINT, INC. | Directeur/Membre du Conseil | 23/06/2022 |
| ░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Ronald Eastman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Manufactures and distributes chemicals | Process Industries |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
IntegenX, Inc.
IntegenX, Inc. BiotechnologyHealth Technology Develops rapid human DNA identification technology, next-gen sequencing library preparation, and DNA/RNA ambient temperature stability and storage products | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
EW Healthcare Partners Fund
 EW Healthcare Partners Fund Investment ManagersFinance Functions as a family of funds | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Williams College
 Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Finance |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
ProteinSimple
 ProteinSimple Medical SpecialtiesHealth Technology Develops and commercializes proprietary systems and consumables for protein analysis | Health Technology |
HCORP, Inc.
 HCORP, Inc. Medical/Nursing ServicesHealth Services Provides interactive patient education, communication and entertainment services for hospital patients. | Health Services |
Buck Institute for Research on Aging
 Buck Institute for Research on Aging Miscellaneous Commercial ServicesCommercial Services Operates independent research institute for connection between aging and chronic disease | Commercial Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Open Monoclonal Technology, Inc.
 Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Engages in the genetic engineering of animals for discovery of human therapeutic antibodies | Health Technology |
Medical, Inc.
Medical, Inc. Medical DistributorsDistribution Services Wholesales and repairs medical equipment | Distribution Services |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Electronic Technology |
Juvenile Diabetes Research Foundation of Arizona, Inc. | |
Epiphany Technology Acquisition Corp.
 Epiphany Technology Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
BioPlus Acquisition Corp.
 BioPlus Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Enterprise 4.0 Technology Acquisition Corp.
 Enterprise 4.0 Technology Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
